Skip to main content

SOLiD Saga

At PolITiGenomics, David Dooling points out a letter that the senior director of scientific operations at ABI, Kevin McKernan, wrote to the UK House of Lords last November. In it, he says that the Sanger Centre is biased against ABI due to the company's association with Craig Venter during the human genome sequencing race and says the center had close ties to Solexa. The Sanger Centre returned five SOLiD instruments and instead purchased more Illumina Genome Analyzers — McKernan's letter included a news story from our sister publication GenomeWeb Daily News on the return of the instruments. "It doesn't seem right to impugn someone else's character in that way when there are countless other reasons -- scientific reasons -- why the Sanger Institute would make that choice," Dooling says to Nature's The Great Beyond blog.

The Scan

Not Kept "Clean and Sanitary"

A Food and Drug Administration inspection uncovered problems with cross contamination at an Emergent BioSolutions facility, the Wall Street Journal reports.

Resumption Recommendation Expected

The Washington Post reports that US officials are expected to give the go-ahead to resume using Johnson & Johnson's SARS-CoV-2 vaccine.

Canada's New Budget on Science

Science writes that Canada's new budget includes funding for the life sciences, but not as much as hoped for investigator-driven research.

Nature Papers Examine Single-Cell, Multi-Omic SARS-CoV-2 Response; Flatfish Sequences; More

In Nature this week: single-cell, multi-omics analysis provides insight into COVID-19 pathogenesis, evolution of flatfish, and more.